Pancreatic Cancer Research

Journal articleMol Ther Nucleic Acids2018

Targeted Delivery of Auristatin-Modified Toxins to Pancreatic Cancer Using Aptamers.

Journal
Mol Ther Nucleic Acids
Published
1 December 2017
Citations
51
Type
Article
License
cc by-nc-nd

These are the paper’s bibliographic details. A summary of its population, design, endpoints and findings, each tied to a quote, has not been written for this paper yet.

Ask this document

Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess.

Try

Source text

abstract cc by-nc-nd

Pancreatic cancer is one of the most lethal malignancies. Treatment with the first-line agent, gemcitabine, is often unsuccessful because it, like other traditional chemotherapeutic agents, is non-specific, resulting in off-target effects that necessitate administration of subcurative doses. … Excerpt only: this text is the publisher’s. Read it in full at the source.